LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Akciju saraksts・NeoGenomics Inc

NeoGenomics Inc

Slēgts

9.23 1.54

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.19

Max

9.25

Galvenie mērījumi
By Trading Economics
Ienākumi	-7.2M -17M
Pārdošana	-3.5M 187M
EPS	0.01
Peļņas marža	-9.164
Darbinieki	2,500
EBITDA	-5.8M -567K

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+61.76% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 28. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-31M 1.1B
Iepriekšējā atvēršanas cena	7.69
Iepriekšējā slēgšanas cena	9.23

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 22. maijs 18:09 UTC

Tirgus saruna

Centralized Crypto Lending Slows in 1Q -- Market Talk

2026. g. 22. maijs 16:54 UTC

Tirgus saruna

Crypto Spot Volumes Fall 14% in April -- Market Talk

2026. g. 22. maijs 14:53 UTC

Tirgus saruna

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

2026. g. 22. maijs 11:51 UTC

Tirgus saruna

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

2026. g. 22. maijs 07:28 UTC

Tirgus saruna

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

2026. g. 21. maijs 17:04 UTC

Tirgus saruna

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

2026. g. 21. maijs 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 21. maijs 16:08 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 21. maijs 16:08 UTC

Tirgus saruna

Zcash Backtracks After Yesterday's Surge -- Market Talk

2026. g. 21. maijs 15:39 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 21. maijs 15:39 UTC

Tirgus saruna

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

2026. g. 21. maijs 13:52 UTC

Tirgus saruna

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

2026. g. 21. maijs 07:03 UTC

Tirgus saruna

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

2026. g. 20. maijs 17:08 UTC

Tirgus saruna

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

2026. g. 20. maijs 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 20. maijs 15:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 20. maijs 15:51 UTC

Tirgus saruna

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

2026. g. 20. maijs 15:39 UTC

Tirgus saruna

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

2026. g. 20. maijs 13:08 UTC

Tirgus saruna

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

2026. g. 20. maijs 12:44 UTC

Tirgus saruna

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

2026. g. 20. maijs 07:25 UTC

Tirgus saruna

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

2026. g. 19. maijs 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 19. maijs 15:54 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 19. maijs 15:54 UTC

Tirgus saruna

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

2026. g. 19. maijs 14:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 19. maijs 14:51 UTC

Tirgus saruna

Ethereum Down From Near-Term High -- Market Talk

2026. g. 19. maijs 08:26 UTC

Tirgus saruna

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

2026. g. 19. maijs 08:26 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2026. g. 18. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 18. maijs 17:22 UTC

Tirgus saruna

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

61.76% augšup

Prognoze 12 mēnešiem

Vidējais 14.93 USD 61.76%

Augstākais 25 USD

Zemākais 11 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

10 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 10 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.